Clinical Trials Directory

Trials / Completed

CompletedNCT01950975

Screening for Chromosomal Microarrangements by CGH-array in Developmental Anomalies of the Skin Suggestive of Mosaicism.

Screening for Chromosomal Microarrangements by CGH-array in Developmental Anomalies of the Skin Suggestive of Mosaicism. National Multicentre Descriptive Study.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
315 (actual)
Sponsor
Centre Hospitalier Universitaire Dijon · Academic / Other
Sex
All
Age
37 Weeks
Healthy volunteers
Not accepted

Summary

The principal result expected is the discovery of inframicroscopic chromosomal rearrangements in regions of the genome not yet known to be involved, or mutations in known candidate genes; The identification of such a mosaic rearrangement in an affected infant would lead to improved genetic counselling. Indeed, as this mosaicism is a consequence of a genetic event occurring at an early stage of embryogenesis, it would be possible to confirm the sporadic nature of the observed disorder and therefore to predict a very low or even negligible risk of recurrence for the couple concerned. For the affected infant, the risk for his/her own offspring will be assessed according to the nature of the genetic anomaly discovered. For medical practice, investigators hope that this study will lead to a clearer definition of the screening modalities for mosaicism in the disorders concerned. In particular, they hope to determine whether or not it is possible to dispense with a skin biopsy, which is more invasive than a blood sample.

Conditions

Interventions

TypeNameDescription
BIOLOGICALPeripheral blood samples in EDTA tubes
PROCEDURESkin biopsies

Timeline

Start date
2012-02-20
Primary completion
2017-09-08
First posted
2013-09-26
Last updated
2024-02-21

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT01950975. Inclusion in this directory is not an endorsement.